the aid library

LIST OPTIONS

Filter

1030

Sort by:

Direction:

Download (594)

View PDF (330)

Consolidated HIV guidelines for prevention, treatment, service delivery & monitoring
recommended

World Health Organization WHO (2021) CC

July 2021. This publication brings together important clinical and programmatic updates produced by WHO since 2016 and provides comprehensive, evidence-informed recommendations and good practice statements within a public health, rights-based and person-centred approach. These guidelines bring in... more

Download (228)

View PDF (658)

Lymphatic Filariasis Increases Tissue Compressibility and Extracellular Fluid in Lower Limbs of Asymptomatic Young People in Central Myanmar

Douglass, Janet; Graves, Patricia; Lindsay, Daniel et al. (2017) CC

Tropical Medicine and Infectious Disease 2017, 2(4), 50
This is a cross-sectional analysis of baseline data in a longitudinal study on asymptomatic, LF antigen-positive and -negative young people in Myanmar. Rapid field screening was used to identify antigen-positive cases and a group of antige... more

Download (106)

View PDF (152)

Gambiense human African trypanosomiasis: the bumpy road to elimination

Hasker E, Hope A, Bottieau E. Wolters Kluwer Health, Inc. (2022) C2

Gambiense human African trypanosomiasis is a deadly infectious disease affecting West and Central Africa, South Sudan and Uganda, and transmitted between humans by tsetse flies. The disease has caused several major epidemics, the latest one in the 1990s. Thanks to recent innovations such as rapid di... more

Download (103)

View PDF (1378)

Cancer in sub-Saharan Africa
recommended

Ngwa, W.; et al. Lancet Oncology Commission (2022) C2

Lancet Oncol 2022; 23: e251–312Published OnlineMay 9, 2022 https://doi.org/10.1016/S1470-2045(21)00720-8 In sub-Saharan Africa (SSA), urgent action is needed to curb a growing crisis in cancer incidence and mortality. Without rapid interventions, data estimates show a major increase in cancer mo... more

Download (229)

View PDF (241)

Determine TB LAM AG Test

Stop TB Parntership; WHO (2019) C_WHO

TEchnical Note

Download (81)

View PDF (510)

Episode #14 - COVID-19 - Tests

World Health Organization WHO (2020) C_WHO

Download (123)

View PDF (151)

Note d’orientation de l’OMS : tests de diagnostic de la COVID-19

Organisation Mondiale de la Santé OMS (2022) C_WHO

Les notes d’orientation exposent les mesures essentielles que les décideurs peuvent mettre en œuvre aux niveaux national et infranational pour les éléments suivants : tests de diagnostic de la COVID-19, prise en charge clinique de la COVID-19, atteinte des cibles en matière de vaccination con... more

Download (200)

View PDF (235)

Testen & COVID-19

Seitz, W.; and S. Mauder MEDBOX (2021) CC

04.März 2021 MEDBOX Issue Brief no. 10 Dieser Issue Brief gibt einen kurzen Überblick über Teststrategie, Testverfahren, Videos zur Handhabung und weiterführende Literatur.

Download (109)

View PDF (135)

COVID-19 diagnostic testing in the context of international travel, scientific brief, 16 December 2020

World Health Organization WHO (2020) C_WHO

Available in English, French, Spanish, Chinese, Russian and Arabic https://apps.who.int/iris/handle/10665/337832

Download (757)

View PDF (1485)

Predictive values of Ebola RDTs and implications for decision-makers

World Health Organization (WHO) (2015) C_WHO

Annex to Selection and use of Ebola in vitro diagnostic assays

Download (367)

View PDF (582)

Screening for Transfusion Transmissible Infections

National AIDSControl (NACO), Government of India; Ministry of Health and Family Welfare (2012) C1

Download (81)

View PDF (138)

Challenges of DHS and MIS to capture the entire pattern of malaria parasite risk and intervention effects in countries with different ecological zones: the case of Cameroon

Massoda Tonye, S.G. ; C. Kouambeng, R. Wounang et. al. Malaria Journal (2018) C1

Massoda Tonye et al. Malar J (2018) 17:156 https://doi.org/10.1186/s12936-018-2284-7 Background: In 2011, the demographic and health survey (DHS) in Cameroon was combined with the multiple indicator cluster survey. Malaria parasitological data were collected, but the survey period did not overl... more

Download (97)

View PDF (140)

Diagnostic testing for SARS-CoV-2: interim guidance, 11 September 2020

World Health Organization WHO (2020) C_WHO

Available in Arabic, Chinese, English, French, Portuguese and Spanish https://apps.who.int/iris/handle/10665/334254

Download (1673)

View PDF (886)

National HIV Testing and Treatment Guidelines 2017
recommended

Nepal, Ministry of Health, National Centre for AIDS and STD Control (2017) C1

Download (71)

View PDF (133)

Advice on the use of point-of-care immunodiagnostic tests for COVID-19

OCHA; Reliefweb; World Health Organization (WHO) OCHA; Reliefweb; World Health Organization (WHO); Health Cluster (2020) C2

Scientific brief 8 April 2020

Download (237)

View PDF (224)

Implementation of simultaneous diagnostic testing for COVID-19 and TB in high TB burden countries

Stop TB Partnership; WHO (2022) C_WHO

Tuberculosis (TB) is the deadliest infectious disease in most low- and middle-income countries, claiming more than 4,000 lives each day. The unprecedented COVID-19 pandemic has seriously impacted people with pre-existing health conditions. People with TB are usually more vulnerable to other infectio... more

Download (84)

View PDF (138)

Information and criteria for prioritizing diagnostic tests for SARS-CoV-2 in order to address the procurement needs of health systems

OPS (2020) C_WHO

This document provides brief information answering common questions regarding COVID-19 diagnostic tests and how to prioritize them to the patients most in need.

Download (28)

View PDF (30)

Mpox Testing Strategy - November 2024

Africa Center for Disease Control and Prevention (2024) CC

Mpox is an emerging zoonotic disease caused by the mpox virus, a member of the Orthopoxvirus genus closely related to the variola virus that causes smallpox. Mpox was first discovered in 1958 when outbreaks of a pox-like disease occurred in monkeys kept for research. The first human case was recorde...d in 1970 in the Democratic Republic of the Congo (DRC) during a period of intensified effort to eliminate smallpox and since then the infection has been reported in a number of African countries. Mpox can spread in humans through close contact, usually skin-to-skin contact, including sexual contact, with an infected person or animal, as well as with materials contaminated with the virus such as clothing, beddings and towels, and respiratory droplets in prolonged face to face contact. People remain infectious from the onset of symptoms until all the lesions have scabbed and healed. The virus may spread from infected animals through handling infected meat or through bites or scratches. Diagnosis is confirmed by polymerase chain reaction (PCR) testing of material from a lesion for the virus’s DNA. Two separate clades of the mpox virus are currently circulating in Africa: Clade I, which includes subclades Ia and Ib, and Clade II, comprising subclades IIa and IIb. Clade Ia and Clade Ib have been associated with ongoing human-to-human transmission and are presently responsible for outbreaks in the Democratic Republic of the Congo (DRC), while Clade Ib is also contributing to outbreaks in Burundi and other countries. In 2022‒2023 mpox caused a global outbreak in over 110 countries, most of which had no previous history of the disease, primarily driven by human-to-human transmission of clade II through sexual contact. In just over a year, over 90,000 cases and 150 deaths were reported to the WHO. For the second time since 2022, mpox has been declared a global health emergency as the virus spreads rapidly across the African continent. On 13 Aug 2024, Africa CDC declared the ongoing mpox outbreak a Public Health Emergency of Continental Security (PHECS), marking the first such declaration by the agency since its inception in 2017.7 This declaration empowered the Africa CDC to lead and coordinate responses to the mpox outbreak across affected African countries. On August 14, 2024, the WHO declared the resurgence of mpox a Public Health Emergency of International Concern (PHEIC) emphasizing the need for coordinated international response. As of August 2024, Mpox has expanded beyond its traditional endemic regions, with new cases reported in countries including Sweden, Thailand, the Philippines, and Pakistan. Sweden has confirmed its first case of Clade 1 variant, which has been rapidly spreading in Africa, particularly in DRC. The emergence of this new variant raises concerns about its potential for higher lethality and transmission rates outside Africa. more